|
3-[(4-methylpiperazin-1-yl)(pyridin-2-yl)methyl]-2-phenyl-1H-indol-1-ol |
|
Burkholderia |
Quorum-sensing |
Preclinical (in vitro) |
Christensen QH, et al. 2013. Proc Natl Acad Sci U S A |
|
4-[(1-hydroxy-2-phenylindol-3-yl)-(4-methylphenyl)methyl]morpholine |
Depiction based on curated SMILES
O
N
OH
H
3
C
N
|
Burkholderia |
Quorum-sensing |
Preclinical (in vitro) |
Christensen QH, et al. 2013. Proc Natl Acad Sci U S A |
|
3-((4-chlorophenyl)(morpholino)methyl)-2-phenyl-1H-indol-1-ol |
Depiction based on curated SMILES
OH
N
Cl
N
O
|
Burkholderia |
Quorum-sensing |
Preclinical (in vitro) |
Christensen QH, et al. 2013. Proc Natl Acad Sci U S A |
|
Ellagic acid |
Depiction based on curated SMILES
OH
OH
O
O
O
O
HO
HO
|
Burkholderia |
Biofilm |
Preclinical (in vitro) |
Huber B, et al. 2003. Z Naturforsch C J Biosci |
|
7-[morpholin-4-yl(pyridin-3-yl)methyl]quinolin-8-ol |
Depiction based on curated SMILES
O
N
N
OH
N
|
Burkholderia |
Quorum-sensing |
Preclinical (in vitro) |
Christensen QH, et al. 2013. Proc Natl Acad Sci U S A |
|
Ethyl 4-((1-hydroxy-2-phenyl-1H-indol-3-yl)(pyridin-2-yl)methyl)piperazine-1-carboxylate |
Depiction based on curated SMILES
N
HO
O
O
N
N
CH
3
N
|
Burkholderia |
Quorum-sensing |
Preclinical (in vitro) |
Christensen QH, et al. 2013. Proc Natl Acad Sci U S A |
|
N-(2-fluorophenyl)-4-methyl-3-(pyridin-4-ylmethylideneamino)-1,3-thiazol-2-imine |
Depiction based on curated SMILES
N
N
N
F
CH
3
N
S
|
Burkholderia |
Quorum-sensing |
Preclinical (in vitro) |
Christensen QH, et al. 2013. Proc Natl Acad Sci U S A |
|
Beta-Resorcylic acid |
Depiction based on curated SMILES
OH
OH
O
HO
|
Campylobacter |
Regulation |
Preclinical (in vitro) |
Ammar AM, et al. 2020. Animals (Basel) |
|
2-[(2E)-2-[(3,5-dibromo-2-hydroxyphenyl)methylidene]hydrazinyl]-2-sulfanylidene-N-[2-(trifluoromethyl)phenyl]acetamide |
Depiction based on curated SMILES
HO
Br
Br
N
N
H
S
O
F
F
F
HN
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Zigangirova NA, et al. 2012. Acta Naturae |
|
2-[(2E)-2-[(3,5-dibromo-2-hydroxyphenyl)methylidene]hydrazinyl]-2-sulfanylidene-N-[3-(trifluoromethyl)phenyl]acetamide |
Depiction based on curated SMILES
OH
Br
Br
N
N
H
S
O
F
F
F
NH
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Zigangirova NA, et al. 2012. Acta Naturae |
|
| | |